Maze Therapeutics Inc. (MAZE) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Maze Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Maze Therapeutics Inc. (MAZE) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $1.8B. It trades at $31.73, up 0.13% today. 9 analysts' average target of $63.13 implies +99.0% from today's price. Kronos AI's 30-day forecast is −13.1% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $63.13 |
| Low – high | $46.00 – $110.00 |
| Analysts | 9 |
| Upside to average | +99.0% |
Kronos AI 30-day forecast
| Expected close | $27.53 (−13.1%) |
| Likely range | −15.3% … −8.9% |
| As of | 2026-10-27 |
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator